Biophysical Mechanisms of the Neutralization of Endotoxins by Lipopolyamines

Endotoxins (lipopolysaccharides, LPS) are one of the strongest immunostimulators in nature, responsible for beneficial effects at low, and pathophysiological effects at high concentrations, the latter frequently leading to sepsis and septic shock associated with high mortality in critical care settings. There are no drugs specifically targeting the pathophysiology of sepsis, and new therapeutic agents are therefore urgently needed. The lipopolyamines are a novel class of small molecules designed to sequester and neutralize LPS. To understand the mechanisms underlying the binding and neutralization of LPS toxicity, we have performed detailed biophysical analyses of the interactions of LPS with candidate lipopolyamines which differ in their potencies of LPS neutralization. We examined gel-to-liquid crystalline phase behavior of LPS and of its supramolecular aggregate structures in the absence and presence of lipopolyamines, the ability of such compounds to incorporate into different membrane systems, and the thermodynamics of the LPS:lipopolyamine binding. We have found that the mechanisms which govern the inactivation process of LPS obey similar rules as found for other active endotoxin neutralizers such as certain antimicrobial peptides.

[1]  Diptesh Sil,et al.  Structure-activity relationships of lipopolysaccharide sequestration in N-alkylpolyamines. , 2009, Bioorganic & medicinal chemistry letters.

[2]  M. Koch,et al.  The generalized endotoxic principle , 2003, European journal of immunology.

[3]  K. Miller,et al.  Lipopolysaccharide sequestrants: structural correlates of activity and toxicity in novel acylhomospermines. , 2005, Journal of medicinal chemistry.

[4]  K. Brandenburg,et al.  Molecular basis for endotoxin neutralization by amphipathic peptides derived from the alpha-helical cationic core-region of NK-lysin. , 2010, Biophysical chemistry.

[5]  D. Fedson Was bacterial pneumonia the predominant cause of death in the 1918-1919 influenza pandemic? , 2009, The Journal of infectious diseases.

[6]  R. Holzheimer Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review , 2001, Journal of chemotherapy.

[7]  H. Gerlach,et al.  Clinical implications of antibiotic-induced endotoxin release in septic shock , 2002, Intensive Care Medicine.

[8]  T. Nguyen,et al.  Controlling plasma protein binding: structural correlates of interactions of hydrophobic polyamine endotoxin sequestrants with human serum albumin. , 2008, Molecular pharmaceutics.

[9]  J. Gegner,et al.  Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.

[10]  B. Lindner,et al.  Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. , 1994, Advances in carbohydrate chemistry and biochemistry.

[11]  Diptesh Sil,et al.  Structure-activity relationships of lipopolysaccharide sequestration in guanylhydrazone-bearing lipopolyamines. , 2009, Bioorganic & medicinal chemistry.

[12]  M. Hornef,et al.  New Antiseptic Peptides To Protect against Endotoxin-Mediated Shock , 2010, Antimicrobial Agents and Chemotherapy.

[13]  M. Koch,et al.  Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. , 2004, Biochemical pharmacology.

[14]  A. Wiese,et al.  Endotoxins: relationships between structure, function, and activity. , 2004, Current topics in medicinal chemistry.

[15]  Walter Richter,et al.  Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. , 2011, Biophysical journal.

[16]  A. Blume,et al.  Insights into protein–polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry , 2009, European Biophysics Journal.

[17]  M. Roessle,et al.  Structural polymorphism of hydrated monoacylated maltose glycolipids. , 2008, Chemistry and physics of lipids.

[18]  K. Brandenburg,et al.  Physicochemical properties of bacterial glycopolymers in relation to bioactivity. , 2003, Carbohydrate research.

[19]  R. Ulevitch,et al.  Analysis of lipopolysaccharide binding by CD14. , 1993, The Journal of biological chemistry.

[20]  M. Koch,et al.  Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide. , 2005, Biophysical journal.

[21]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[22]  Diptesh Sil,et al.  Pharmacokinetics of DS-96, an alkylpolyamine lipopolysaccharide sequestrant, in rodents. , 2008, Journal of pharmaceutical sciences.

[23]  G. Jung,et al.  Physicochemical and biological analysis of synthetic bacterial lipopeptides : Validity of the concept of ’ endotoxic conformation ’ 1 , 2003 .

[24]  K. Brandenburg,et al.  Peptide-based treatment of sepsis , 2011, Applied Microbiology and Biotechnology.

[25]  T. Hartung,et al.  β-lactam antibiotic-induced release of lipoteichoic acid from Staphylococcus aureus leads to activation of neutrophil granulocytes , 2006, Annals of Clinical Microbiology and Antimicrobials.

[26]  T. Nguyen,et al.  Bound To Shock: Protection from Lethal Endotoxemic Shock by a Novel, Nontoxic, Alkylpolyamine Lipopolysaccharide Sequestrant , 2007, Antimicrobial Agents and Chemotherapy.

[27]  G. Dennis Shanks,et al.  Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic , 2008, Emerging infectious diseases.

[28]  J. Taubenberger,et al.  Influenza : the Mother of All Pandemics , 2022 .

[29]  C. Galanos,et al.  A new method for the extraction of R lipopolysaccharides. , 1969, European journal of biochemistry.

[30]  T. Goldmann,et al.  Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors , 2013, Antimicrobial Agents and Chemotherapy.

[31]  K. Brandenburg,et al.  Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis. , 2007, The Biochemical journal.

[32]  Buko Lindner,et al.  Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. , 2002, European journal of biochemistry.

[33]  Diptesh Sil,et al.  Development of small-molecule endotoxin sequestering agents. , 2010, Sub-cellular biochemistry.

[34]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[35]  T. Nguyen,et al.  Polycationic sulfonamides for the sequestration of endotoxin. , 2007, Journal of medicinal chemistry.

[36]  T. Nguyen,et al.  Protection from endotoxic shock by EVK-203, a novel alkylpolyamine sequestrant of lipopolysaccharide. , 2007, Bioorganic & medicinal chemistry.

[37]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  K. Brandenburg,et al.  The physicochemistry of endotoxins in relation to bioactivity. , 2007, International journal of medical microbiology : IJMM.

[39]  K. Brandenburg,et al.  Biophysical Characterization of Endotoxin Inactivation by NK-2, an Antimicrobial Peptide Derived from Mammalian NK-Lysin , 2004, Antimicrobial Agents and Chemotherapy.

[40]  M. Koch,et al.  Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. , 2007, Biophysical journal.

[41]  K. Brandenburg,et al.  Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide. , 2004, European journal of biochemistry.